SCHEMBL12795443

SCHEMBL12795443

COc1cncc(-c2cc3cc[nH]c(=O)c3c(Nc3ccc(C4CCN(C(C)C(=O)NC(C)C)CC4)c(C)c3)n2)n1

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 17/20 0.71
FER P16591 1/20 0.35
SYK P43405 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158279 0.94 ZAP70 (0.73) ZAP70FERSYK
SCHEMBL1158511 0.93 ZAP70 (0.70) ZAP70FERSYK
SCHEMBL1158101 0.92 ZAP70 (0.74) ZAP70FERSYK
SCHEMBL1158522 0.92 ZAP70 (0.74) ZAP70FERSYK
SCHEMBL1158218 0.92 ZAP70 (0.74) ZAP70FERSYK
SCHEMBL12795439 0.92 ZAP70 (0.74) ZAP70FERSYK
SCHEMBL1158822 0.92 ZAP70 (0.69) ZAP70SYK
SCHEMBL1159696 0.91 ZAP70 (0.78) ZAP70FERSYK
SCHEMBL1158747 0.91 ZAP70 (0.68) ZAP70SYK
SCHEMBL1158438 0.91 ZAP70 (0.71) ZAP70FERSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US disclosed
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS IRM LLC (BM) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053897-A1 COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS SYK, BTK, LYN ZAP70 5/4885FER 89/4885SYK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.